HMGB3 is a potential diagnostic marker for early cervical lesion screening

HMGB3 is a potential diagnostic marker for early cervical lesion screening

Bibliographic Details
Main Authors:	Qianwen Cui, Jiarong Zhao, Qingmei Deng, Yu Liu, Changfang Fu, Qiang Wu, Qiuyan Sun, Haiyan Weng, Haiming Dai, Wulin Yang
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-11-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223000855

Similar Items

The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
by: Lei Hu, et al.
Published: (2023-01-01)

Significance Of Cervical Cytology Screening (Pap Smear) In The Detection Of Precancerous Cervical Lesions
by: Issraa A. Al-Shammari, et al.
Published: (2007-10-01)

Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy
by: Oyeon Cho, et al.
Published: (2021-11-01)

Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells
by: Lifang You, et al.
Published: (2021-01-01)

Precancerous cervical lesion screening acceptance among women in Eastern Ethiopia
by: Endalew G Sendo, et al.
Published: (2023-11-01)

The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer
by: Aneta Popiel-Kopaczyk, et al.
Published: (2023-04-01)

Evaluating the p53 as diagnostic marker by using liquid based cervical sample in cervical carcinogenesis
by: Zin, Anani Aila Mat
Published: (2019)

HMGB-1 in Psoriasis
by: Marco Casciaro, et al.
Published: (2021-12-01)

Establishment of early diagnosis models for cervical precancerous lesions using large-scale cervical cancer screening datasets
by: Bo Meng, et al.
Published: (2022-11-01)

Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia
by: O. V. Khoperskaya, et al.
Published: (2022-01-01)

Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies
by: Lars Schröder, et al.
Published: (2023-10-01)

PRECANCEROUS CERVICAL LESIONS
by: E. A. Mezhevitinova, et al.
Published: (2016-12-01)

A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes
by: Jingyu Zhao, et al.
Published: (2023-07-01)

Potential diagnostic value of quantitative superb microvascular imaging in premalignant and malignant cervical lesions
by: Yi Zhu, et al.
Published: (2023-08-01)

Electrochemical DNA biosensor coupled to LAMP reaction for early diagnostics of cervical precancerous lesions
by: Ravery Sebuyoya, et al.
Published: (2022-12-01)

Expression of cytokeratins 8 and 17 as a diagnostic marker of cervical intraepithelial neoplasia
by: Kalodimos George, et al.
Published: (2010-01-01)

Structural Characteristics of High-Mobility Group Proteins HMGB1 and HMGB2 and Their Interaction with DNA
by: Tatiana Y. Starkova, et al.
Published: (2023-02-01)

Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways
by: Zhi-Hai Deng, et al.
Published: (2020-01-01)

Photodynamic therapy for cervical lesions
by: E. V. Grebenkina, et al.
Published: (2014-06-01)

Diagnostic utility of pap smear and visual inspection of acetic acid for the detection of various cervical lesions
by: Rashmi Jain, et al.
Published: (2022-09-01)

Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis
by: Arzu SAĞLAM, et al.
Published: (2017-09-01)

The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer
by: Martín Salamini-Montemurri, et al.
Published: (2024-03-01)

Npro of classical swine fever virus enhances HMGB1 acetylation and its degradation by lysosomes to evade from HMGB1-mediated antiviral immunity
by: Xiao Han, et al.
Published: (2024-01-01)

A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches
by: Tudor Gisca, et al.
Published: (2024-02-01)

Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia
by: Hazem Mahmoud Al-Mandeel, et al.
Published: (2016-09-01)

Diagnostic Value of SMARCE1 and CRISP3 Combined with Tumor Markers in Cervical Cancer
by: Lijie He, et al.
Published: (2023-02-01)

Diagnostic Value of High-Mobility Group Box 1 (HMGB1) Protein in Acute and Perforated Appendicitis
by: Shabanali Alizadeh, et al.
Published: (2018-01-01)

Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study.
by: Hirut Teame, et al.
Published: (2018-01-01)

Structure and Functions of HMGB2 Protein
by: Tatiana Starkova, et al.
Published: (2023-05-01)

The role of HMGB1 in digestive cancer
by: Xiangqi Chen, et al.
Published: (2023-11-01)

HMGB1 in Systemic Lupus Erythematosus
by: Tianye Liu, et al.
Published: (2020-05-01)

HMGB1 redox during sepsis
by: Wasan Abdulmahdi, et al.
Published: (2017-10-01)

Cytokine balance as a diagnostic marker of inflammation in experimental purulent lesions of soft tissues
by: A. S. Solovyeva, et al.
Published: (2023-02-01)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
by: Yan Sun, et al.
Published: (2018-07-01)

Predictors of Precancerous Cervical Lesions Among Women Screened for Cervical Cancer in Bahir Dar Town, Ethiopia: A Case–Control Study
by: Alamiraw JA, et al.
Published: (2020-07-01)

Multiple Faces of Cervical Lesions in Children
by: Stefana Maria Moisa, et al.
Published: (2022-03-01)

Intraepithelial cervical lesions in indigenous in Ecuador
by: Zoila Katherine Salazar Torres, et al.
Published: (2019-12-01)

Critical review of noncarious cervical lesions
by: Keerthi Venkatesan, et al.
Published: (2018-01-01)

Overtreatment in treatment of cervical intraepithelial lesions
by: N. Kashtalian, et al.
Published: (2018-11-01)

Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
Published: (2013-01-01)